Most cases of EBV+ DLBCL, particularly in Asia, have shown an activated B cell (ABC)-like immunophenotype, which is consistent with the substantial NF-κB activation that was revealed by immunohistochemistry and gene expression profiles [4, 8, 10–11]. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.